Toxicity Issues Research Articles

Synergistic effect of Silver-Nanodiamond composite as an efficient antibacterial agent against E. coli and S. aureus

Bacterial antimicrobial resistance (BAMR) seems to pose the greatest threat to public health, food safety, and agriculture in this century. The development of novel efficient antimicrobial agents to combat bacterial infections has become a global issue. Silver nanoparticles (Ag NPs) appeared as a feasible alternative to antibiotics. However, Ag NPs face cost, toxicity, and aggregation issues which limit their antibacterial activity. This work aims to stabilize Ag NPs with enhanced antimicrobial activity at comparatively lower Ag concentrations to prevent bacterial infections. For this purpose, the Ag core was covered with nanodiamonds (NDs). Ag-NDs composite have been synthesized by microplasma technique. TEM analysis confirmed the presence of both Ag and NDs in the Ag-NDs composite. A particle size (∼19 nm) was reported for Ag-NDs at the highest concentration as compared to Ag NPs (∼3 nm). The conduction band of the diamond acted as an extremely strong reducing agent for Ag NPs. The large surface area of NDs stabilized the Ag NPs. A redshift (∼400 nm–406 nm) in UV–visible spectra of the Ag-NDs composite indicated the formation of bigger-sized Ag NPs after incorporating NDs. XRD and LIBS analysis verified the increase in intensity of Ag-NPs by increasing ND concentration. The presence of functional groups including OH, CH, and Ag/Ag2O was confirmed by FTIR. Bacterial inhibition growth appeared to be a dose-dependent process. The minimum inhibition concentration value of Ag-NDs composite at the highest NDs concentration against E. coli (∼ 0.69 μg/ml) and S. aureus (∼44 μg/ml). This is the first study to report the smallest MIC for E. coli (<1 μg/ml). Ag-ND composites emerged to be more efficient than Ag NPs and preferred to be used against BAMR. The enhanced antibacterial activity of the Ag-NDs composite makes it a potential candidate for antibiotics, food products, and pesticides.

Considering Grouped or Individual Non-Methane Volatile Organic Compound Emissions in Life Cycle Assessment of Composting Using Three Life Cycle Impact Assessment Methods

Composting is a waste management practice that converts organic waste into a product that can be used safely and beneficially as a bio-fertiliser and soil amendment. Non-methane volatile organic compounds (NMVOCs) from composting are known to cause damage to human health and the environment. The impact of waste management on the environment and workers is recognised as a growing environmental and public health concern. Measurements of NMVOCs emitted during composting have been carried out only in a few studies. NMVOC emissions are typically reported as a group rather than as species or speciation profiles. Recognising the need to investigate the issues associated with NMVOCs, the objective of this study is to estimate variation in life cycle assessment (LCA) results when NMVOCs are considered individual emissions compared to grouped emissions and to compare midpoint and endpoint life cycle impact assessment (LCIA) methods. In general, the ReCiPe 2016 LCIA method estimated the highest impact from the composting process in comparison to IMPACT World+ and EF 3.0 for the impact categories of ozone formation, stratospheric ozone depletion, and particulate matter formation. For ReCiPe 2016 and IMPACT World+, the NMVOC emissions were not linked to human toxicity characterisation factors, meaning that the contribution from NMVOC towards human health risks in and around composting facilities could be underestimated. Using individual NMVOCs helps to additionally estimate the impacts of composting on freshwater ecotoxicity and human carcinogenic and non-carcinogenic toxicity potential. If ecotoxicity or toxicity issues are indicated, then LCA should be accompanied by suitable risk assessment measures for the respective life cycle stage.

Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.

Efflux is a natural process found in all prokaryotic and eukaryotic cells that removes a diverse range of substrates from inside to outside. Many antibiotics are substrates of bacterial efflux pumps, and modifications to the structure or overexpression of efflux pumps are an important resistance mechanism utilized by many multidrug-resistant bacteria. Therefore, chemical inhibition of bacterial efflux to revitalize existing antibiotics has been considered a promising approach for antimicrobial chemotherapy over two decades, and various strategies have been employed. In this review, we provide an overview of bacterial multidrug resistance (MDR) efflux pumps, of which the resistance nodulation division (RND) efflux pumps are considered the most clinically relevant in Gram-negative bacteria, and describe over 50 efflux inhibitors that target such systems. Although numerous efflux inhibitors have been identified to date, none have progressed into clinical use because of formulation, toxicity, and pharmacokinetic issues or a narrow spectrum of inhibition. For these reasons, the development of efflux inhibitors has been considered a difficult and complex area of research, and few active preclinical studies on efflux inhibitors are in progress. However, recently developed tools, including but not limited to computational tools including molecular docking models, offer hope that further research on efflux inhibitors can be a platform for research and development of new bacterial efflux inhibitors.

Multiplex genetic manipulations in Clostridium butyricum and Clostridium sporogenes to secrete recombinant antigen proteins for oral-spore vaccination

BackgroundClostridium spp. has demonstrated therapeutic potential in cancer treatment through intravenous or intratumoral administration. This approach has expanded to include non-pathogenic clostridia for the treatment of various diseases, underscoring the innovative concept of oral-spore vaccination using clostridia. Recent advancements in the field of synthetic biology have significantly enhanced the development of Clostridium-based bio-therapeutics. These advancements are particularly notable in the areas of efficient protein overexpression and secretion, which are crucial for the feasibility of oral vaccination strategies. Here, we present two examples of genetically engineered Clostridium candidates: one as an oral cancer vaccine and the other as an antiviral oral vaccine against SARS-CoV-2.ResultsUsing five validated promoters and a signal peptide derived from Clostridium sporogenes, a series of full-length NY-ESO-1/CTAG1, a promising cancer vaccine candidate, expression vectors were constructed and transformed into C. sporogenes and Clostridium butyricum. Western blotting analysis confirmed efficient expression and secretion of NY-ESO-1 in clostridia, with specific promoters leading to enhanced detection signals. Additionally, the fusion of a reported bacterial adjuvant to NY-ESO-1 for improved immune recognition led to the cloning difficulties in E. coli. The use of an AUU start codon successfully mitigated potential toxicity issues in E. coli, enabling the secretion of recombinant proteins in C. sporogenes and C. butyricum. We further demonstrate the successful replacement of PyrE loci with high-expression cassettes carrying NY-ESO-1 and adjuvant-fused NY-ESO-1, achieving plasmid-free clostridia capable of secreting the antigens. Lastly, the study successfully extends its multiplex genetic manipulations to engineer clostridia for the secretion of SARS-CoV-2-related Spike_S1 antigens.ConclusionsThis study successfully demonstrated that C. butyricum and C. sporogenes can produce the two recombinant antigen proteins (NY-ESO-1 and SARS-CoV-2-related Spike_S1 antigens) through genetic manipulations, utilizing the AUU start codon. This approach overcomes challenges in cloning difficult proteins in E. coli. These findings underscore the feasibility of harnessing commensal clostridia for antigen protein secretion, emphasizing the applicability of non-canonical translation initiation across diverse species with broad implications for medical or industrial biotechnology.

MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos

Cervical cancer cells possess high levels of reactive oxygen species (ROS); thus, increasing oxidative stress above the toxicity threshold to induce cell death is a promising chemotherapeutic strategy. However, the underlying mechanisms of cell death are elusive, and efficacy and toxicity issues remain. Within DNA, 8-oxo-7,8-dihydroguanine (8-oxoG) is the most frequent base lesion repaired by 8-oxoguanine glycosylase 1 (OGG1)-initiated base excision repair. Cancer cells also express high levels of MutT homolog 1 (MTH1), which prevents DNA replication-induced incorporation of 8-oxoG into the genome by hydrolyzing 8-oxo-7,8-dihydro-2′-deoxyguanosine 5′-triphosphate (8-oxo-dGTP). Here, we revealed that ROS-inducing agents triggered cervical cancer to undergo parthanatos, which was mainly induced by massive DNA strand breaks resulting from overwhelming 8-oxoG excision by OGG1. Furthermore, the MTH1 inhibitor synergized with a relatively low dose of ROS-inducing agents by enhancing 8-oxoG loading in the DNA. In vivo, this drug combination suppressed the growth of tumor xenografts, and this inhibitory effect was significantly decreased in the absence of OGG1. Hence, the present study highlights the roles of base repair enzymes in cell death induction and suggests that the combination of lower doses of ROS-inducing agents with MTH1 inhibitors may be a more selective and safer strategy for cervical cancer chemotherapy.

Awareness of possible complications associated with direct composite restorations: A multinational survey among dentists from 13 countries with meta-analysis

ObjectivesResin-based composites (RBCs) evolved into favoured materials for teeth restorations, marking a significant change in dental practice. Despite many advantages, RBCs exhibit various limitations in their physical and chemical properties. Therefore, we assessed the dentists' awareness of possible complications after direct composite restorations and their opinions about this material. MethodsThe online questionnaire was created in English in May 2023. A 16-item survey was dedicated to general dentists and specialists. The first section included four questions related to demographic characteristics. The second section comprised twelve questions and focused on awareness of potential side effects of composite restorations, the most crucial advantages and disadvantages of composite resins, and the frequency of experienced clinical complications after the application of composite materials. ResultsA total of 1830 dentists from 13 countries took part in the survey. Dentists most often declared awareness of low adhesion to the dentine (77.5 %) and, most rarely, solubility in oral fluids (42.6 %). Aesthetics was identified as the main advantage of composite fillings (79 %), followed by the possibility of repair (59 %) and adhesion to enamel (57 %). Polymerisation shrinkage was a major disadvantage for most countries (70 % overall). Analysing the declared potential clinical complications for all countries, statistically significant findings were obtained for marginal discolouration (OR=2.982, 95 % CI: 1.321–6.730, p-value=0.009) and borderline significance for secondary caries (OR=1.814, 95 % CI: 0.964–3.415, p-value=0.065). ConclusionsDentists value aesthetics and repairability but are aware of shrinkage and experience discolouration. The issue of toxicity and solubility seems to be the least known to dentists.Clinical significance: Dentists should use RBCs with critical caution due to possible side effects. Despite the undoubted aesthetics of direct composite restorations, it is necessary to remember potential clinical complications such as marginal discolouration or secondary caries.

The genus Ranunculus L. (Ranunculus) in Asia: a review of its botany, traditional uses, phytochemistry, pharmacology, toxicity, and pharmaceutical preparations.

Ranunculus L. genus contains 413 species, and it is the biggest genus in the family Ranunculaceae Juss. This review is to provide botanical characteristics, traditional uses, phytochemistry, pharmacology, toxicity, and pharmaceutical preparations of the genus Ranunculus. The genus Ranunculus contains flavonoids, organic acids, coumarins, lactones, glycosides, sterols, polysaccharides, and trace elements. These chemical constituents complement the pharmacological actions and work together to exert anti-inflammatory, anticancer, antitubercular, antibacterial, antimalarial, etc. Those traditional Chinese medicine characteristics, like clearing away heat and detoxification, make this genus significant in ethnic medicine. The progress in research and the development of various pharmaceutical preparations made it appear in epidemiological and clinical studies. The genus Ranunculus has attracted the attention of experts and scholars in many fields due to its unique advantages. However, there are many species that are not scientifically investigated. The toxicity issues are also a huge concern. Fortunately, the toxicity can be overcome via special processes like drying or heating and by choosing a safe extraction solvent, such as water thus ensuring the safety of medication. Pharmaceutical preparations containing the plants from Ranunculus have gratifying clinical value, but they are not promoted sufficiently. Therefore, further research should be carried out to promote the genus for its health benefits to humans.

Isocyanate‐chitin modified microspheres for chiral drug separation in high performance liquid chromatography

AbstractIn this work, a two‐step activated swelling technique was effectively employed to successfully synthesize monodisperse porous poly(styrene‐divinylbenzene) (PS‐DVB) particles. Diazoresin (DR) transform an ionic bond into a covalent bond by photoreaction. Under ultraviolet irradiation, DR was used to covalently attach dichlorophenyl isocyanate to sulfonated PS‐DVB microspheres. The novel photo‐crosslinking reaction effectively overcomes the toxicity issues associated with conventional coupling agents and enables green production of chromatographic fillers. Modified PS‐DVB particles were indeed commonly used as filler material for the separation of chiral compounds by high performance liquid chromatography (HPLC). The porous modified microspheres designed effectively separate benzoone, DL‐mandelic acid, 2‐phenylcyclohexanone, ibuprofen, 2‐hydroxyl flavone, DL‐cysteine, chloraniline maleate, hesperidin, and other chiral compounds by 100 mm column. It is noteworthy that the isocyanate‐chitin modified microspheres are effective in separating chiral drugs (1000 μg/mL) within 5 min. Compared with ordinary microspheres, porous isocyanate‐chitin modified microspheres showed better separation efficiency under the same conditions. The enhancement is attributed to the increase in their specific surface area. Consequently, they are a better choice of chromatographic packing matrix.

Peptide-drug conjugate designated for targeted delivery to HER2-expressing cancer cells.

Targeted therapy of the highest globally incident breast cancer shall resolve the issue of off-target toxicity concurring with augmented killing of specific diseased cells. Thus, the goal of this study was to prepare a peptide-drug conjugate targeting elevated expression of HER2 receptors in breast cancer. Towards this, the rL-A9 peptide was conjugated with the chemotherapeutic drug doxorubicin (DOX) through a N-succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) linker. The synthesized peptide-drug conjugate, rL-A9-DOX, was characterized by mass spectrometry. Molecular docking studies, based on binding energy data, suggested a stronger interaction of rL-A9-DOX with the HER2 receptor in comparison to the unconjugated peptide, rL-A9. The cytotoxic effect of the rL-A9-DOX conjugate was observed to be higher in HER2-positive SKOV3 cells compared to HER2-negative MDA-MB-231 cells, indicating selective cell killing. Cellular internalization of the rL-A9-DOX conjugate was evident from the flow cytometry analysis, where a noticeable shift in mean fluorescent intensity (MFI) was observed for the conjugate compared to the control group. This data was further validated by confocal microscopy, where the fluorescent signal ascertained nuclear accumulation of rL-A9-DOX. The present studies highlight the promising potential of rL-A9-DOX for targeted delivery of the drug into a defined group of cancer cells.

The use of T-cells with chimeric antigen receptor (CAR-T) in combination with chemotherapy and radiotherapy for the treatment of solid tumors

The introduction of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematological diseases, particularly in combating blood cancer. The success of this cell therapy approach has led to the development of approximately seven commercial CAR-T based drugs. However, the application of CAR-T therapy for solid tumors has proven to be less effective due to challenges such as the varied antigens in solid tumors, an immunosuppressive tumor environment, limited immune cell infiltration, reduced CAR-T cell activity and toxicity issues. To solve these problems, scientists are making efforts to improve and improve the methods of treatment of solid tumors. Chemotherapy is the standard treatment for a large number of malignant neoplasms. It is also used before starting cell therapy for lymphodepletion and better engraftment of injected CAR-T cells. It has been shown that chemotherapy can reduce the immunosuppressive effect of the tumor microenvironment, destroy the stroma, and promote better infiltration of the tumor by CAR-T cells, improving their survival, persistence, cytotoxicity, and influencing the metabolism of immune cells inside the tumor. The effectiveness of combining chemotherapy and CAR-T cell therapy relies on various factors such as tumor type, dosage, treatment schedule, CAR-T cell composition, and individual biological traits. Similarly, radiation therapy can enhance tumor cell vulnerability to specific treatments while also supporting tumor cell survival.In this review, we discuss the use of CAR-T therapy to combat solid tumors, regarding the challenges of treating solid tumors, ways to overcome them, and also touch upon the possibility of using combination treatments to improve the effectiveness of cell therapy.

Can Asiatic Acid from Centella asiatica Be a Potential Remedy in Cancer Therapy?-A Review.

Centella asiatica has been recognized for centuries in Eastern medicine for its pharmacological properties. Due to the increasing prevalence of oncological diseases worldwide, natural substances that could qualify as anticancer therapeutics are becoming increasingly important subjects of research. This review aims to find an innovative use for asiatic acid (AA) in the treatment or support of cancer therapy. It has been demonstrated that AA takes part in inhibiting phosphorylation, inducing cell death, and reducing tumor growth and metastasis by influencing important signaling pathways, such as PI3K, Akt, mTOR, p70S6K, and STAT3, in cancer cells. It is also worth mentioning the high importance of asiatic acid in reducing the expression of markers such as N-cadherin, β-catenin, claudin-1, and vimentin. Some studies have indicated the potential of asiatic acid to induce autophagy in cancer cells through changes in the levels of specific proteins such as LC3 and p62. It can also act as an anti-tumor immunotherapeutic agent, thanks to its inductive effect on Smad7 in combination with naringenin (an Smad3 inhibitor). It seems that asiatic acid may be a potential anticancer drug or form of adjunctive therapy. Further studies should take into account safety and toxicity issues, as well as limitations related to the pharmacokinetics of AA and its low oral bioavailability.

Antibacterial activity of natural-based toothpaste incorporated with nanohydroxyapatite from fish bone against dental caries bacteria

Toothpaste formulation development has become important due to dental health problems. There has been a large array of improvements in the formulation including fluoride and microbeads (MBs) incorporation. However, the typical problems of the current toothpaste formulation are caused due to the fluoride and MBs toxicity issues on consumer health and aquatic animals. There is an urgent need to rectify this problem through the development of environmentally friendly hydroxyapatite (HAp) toothpaste using different natural components. This study was set out to determine the optimum gelling agent in toothpaste formulation and to investigate the effect of different combinations of the components in HAp-based toothpaste against Streptococcus mutans. The antibacterial activity of the developed toothpaste formulation was investigated using a well-diffusion method and the optimum concentration of the gelling agent (Arabic gum) was determined using a rheometer. One of the most significant findings in the study was the optimum concentration of the gelling agent was found at 55% and a combination of formulation with clove oil (CO) demonstrated the largest size of inhibition against S. mutans (CO = 24 mm, CO with formulation = 11 mm) compared to the other tested components. Findings from this study have suggested that the combination of formulation in HAp-based toothpaste with CO demonstrated the best bacterial inhibitory effect and the optimum gelling agent was at 55%. The overall finding is particularly important in the formulation development of HAp-based toothpaste, thus contributing to an increased supply of HAp in meeting its demand in the Halal market.

Manufacturing Process of CAR-T Therapy and Assessment of the Optimization Potential

One ground-breaking novel treatment that is being utilized extensively in the field of cancer treatment is chimeric antigen receptor (CAR)-T cell therapy. Three axes are used by CAR-T cells to promote tumor killing: Targeting the antigen-positive fraction is the Perforin and Granzyme axis; Targeting the antigen-negative fraction is the Fas and FasL axis; and Cytokine release is focused on the Stromal cell. As a result of this technology's widespread use, its benefits and applications have increased; yet, drawbacks and toxicities have also been discovered. The wide range of uses for this cutting-edge technology has resulted in an increase in its advantages and uses. Alongside these benefits, studies have also discovered negative effects and toxicities related to its usage. This work analyzes the complexities of the specialized immunotherapy mechanism, the difficulties associated with this technology, toxicity issues, and future directions in the treatment of CAR-T cells. Its potential to completely transform the way cancer is treated is becoming more and more evident as the medical community works to understand the intricacies of this innovative therapy.

Advantageous occupation of Cu2+ in the B site of double-perovskite Rb2BB'Br6 (B = K; B′ = Bi) framework for white-light-emission

Research on lead-free double perovskite has demonstrated its potential as a solution to the stability and toxicity issues associated with lead-based inorganic perovskite white light-emitting diodes (WLED). This current investigation was designed to fabricate, examine, and compare the photoluminescence (PL) characteristics of Cu2+-activated Rb2BB'Br6 (B = K and B′ = Bi) double-perovskite (DP) [A2BB'Br6] luminous materials. Bi3+ ions are substituted with Cu2+ ions at their B′ sites. These ions are distributed to the equilibrium valence state and demonstrate minimal variation in ion radius. The microstructure and phase purity of Rb2BB'Br6:Cu2+ DP were assessed by scanning electron microscopy (SEM) and X-ray diffraction (XRD). The Rietveld refinement was also used to identify the crystal structures, and the resulting samples all exhibit cubic crystal structures. The Fm3m space group in Rb2BB'Br6 DP frameworks is significantly impacted by the B sites. The PL spectra were used to thoroughly examine the associated mechanism of the Cu2+ → Bi3+ energy-transfer process. Cu2+ ions can be successfully doped in the Rb2KBiBr6 host with an optical band gap (Eg) of 2.74 eV (RKBBr: 0.025Cu2+). The Rb2KBiBr6:Cu2+ phosphor exhibits distinct emission bands from 450 to 650 nm upon UV excitation at 366 nm. The Cu2+→ Bi3+ energy transfer design allows for systematic luminescence tuning from blue to white due to spectral overlap between the Cu2+ emission and Bi3+ excitation spectra. It has been established that Cu2+ → Bi3+ energy transfer significantly increases the white emission intensity of Bi3+, with an associated colour temperature of 7892 K and an outstanding colour rendering index of 88.8. As a down-conversion luminous material in solid-state illumination for the upcoming generation of display devices, the discovered Rb2KBiBr6: 0.025Cu2+ phosphor exhibits remarkable promise.

Smart multi‐functional aggregates reoxygenate tumor microenvironment through a two‐pronged strategy to revitalize cancer immunotherapy

AbstractPD‐1/PD‐L1 inhibitors have emerged as standard treatments for advanced solid tumors; however, challenges such as a low overall response rate and systemic side effects impede their implementation. Hypoxia drives the remodeling of the tumor microenvironment, which is a leading reason for the failure of immunotherapies. Despite some reported strategies to alleviate hypoxia, their individual limitations constrain further improvements. Herein, a novel two‐pronged strategy is presented to efficiently address hypoxia by simultaneously adopting atovaquone (ATO, inhibiting oxygen consumption) and oxyhemoglobin (HbO2, directly supplementing oxygen) within a multifunctional aggregate termed NPs‐aPD‐1/HbO2/ATO. In addition to eliminating hypoxia with these two components, this smart aggregate also includes albumin and an ROS‐responsive cross‐linker as a controlled release scaffold, along with PD‐1 antibody (aPD‐1) for immunotherapy. Intriguingly, NPs‐aPD‐1/HbO2/ATO demonstrates exceptional tumor targeting in vivo, exhibiting ≈4.2 fold higher accumulation in tumors than in the liver. Consequently, this aggregate not only effectively mitigates hypoxia and significantly assists aPD‐1 immunotherapy but also simultaneously resolves the targeting and systemic toxicity issues associated with individual administration of each component. This study proposes substantial implications for drug‐targeted delivery, addressing tumor hypoxia and advancing immunotherapy, providing valuable insights for advancing cancer treatment strategies.

Unlocking the potential of antisolvent-free perovskite solar cells: Modulating crystallization and intermediates through a binary volatile additive strategy

High-quality perovskite polycrystalline thin films are generally achieved through antisolvent-assisted crystallization, a crucial process that facilitates desolvation. However, antisolvent method is limited by issues of toxicity and fabrication complexity. Here, we introduce a “binary volatile additive” strategy using methylammonium chloride (MACl) and trifluoroacetamide (TFAA) in dimethylformamide/N-methyl-2-pyrrolidone co-solvent system, enabling end-to-end management of antisolvent-free crystallization process. Combining in-situ characterizations and DFT calculations, we prove that TFAA adjusts coordination with perovskite intermediates, facilitating solvent removal and promoting the formation of nuclei, while MACl reduces the formation energy of α-phase formamidinium-based perovskite. Moreover, TFAA not only releases the residual strain caused by MACl, but also in combination with MACl, synergistically widens crystallization window and regulates ripening process, allowing for precise fabrication of homogeneous perovskite films with suppressed defects. By employing the “binary volatile additive” approach, we achieve perovskite solar cells with a power conversion efficiency up to 22.4% and elongated storage life (93% PCE retention over 1000 hours). Our study offers a simple and sustainable approach to produce high-quality perovskite films without the acquisition of antisolvent, streamlining the fabrication process.

The status of nanoneusurgery investigated

Nanoneurosurgery, introduced in 2003, aims to revolutionize neurosurgery using nanotechnology. Despite early excitement, its development has been slower than expected. The field encompasses various neurosurgical domains, utilizing advanced technologies like femtosecond laser and nanoparticle-enhanced stem cell therapies. However, challenges such as diagnostic limitations, nanoparticle toxicity, and ethical issues have impeded progress. Recent trends show a decline in research activity, suggesting a need for more interdisciplinary approaches and practical applications. The field remains distant from fully integrating nanotechnology, indicating that its future impact might be indirect and gradual. Continued research and collaboration are essential for realizing its potential.

Controllable release of Cu ions contributes to the enhanced environmentally-friendly performance of antifouling Cu-bearing stainless steel coating prepared using high-velocity air fuel

Organic antifouling coatings represent an economical and efficient solution for addressing the marine biofouling. However, their application is constrained by issues of durability and toxicity. Therefore, this study has developed a metal-based antifouling coating by utilizing pre-alloyed copper-bearing stainless steel (Cu-bearing SS) powder in conjunction with high-velocity air fuel (HVAF) technology, aiming to achieve an environmentally-friendly and long-lasting antifouling coating. Compared to the self-polishing copolymer (SPC) coating, the adhesion strength of Cu-bearing SS coating increased to 69.0 MPa, which is approximately a 33-fold increase. The coating also exhibited enhanced wear resistance, the width and depth of the wear track for the Cu-bearing SS coating decreased 42.9 % and 81.0 %, respectively. Furthermore, the coating still demonstrated strong inhibitory effects on typical fouling microorganisms and algae adhesion due to Cu ions release process environmentally-friendly. The electrochemical techniques coupling with surface morphology observations were used to elucidate the antifouling mechanism. The variation trend of coating corrosion current was consistent with the release process of Cu ions, which was directly related to the evolution of the coating surface morphology. The three-stage change in the surface morphology of the 304 L-Cu SS coating contributes to the formation of a cyclic variation trend process of Cu ions. The evolution of surface morphology, accompanied by the controlled release process of Cu ions, had become a distinctive feature of antifouling properties for a metal-based coating.

Mathematical Modeling and Optimization of Highly Efficient Nontoxic All-Inorganic CsSnGeI3-Based Perovskite Solar Cells with Oxide and Kesterite Charge Transport Layers.

Despite exceptional optoelectronic properties and rapidly increasing efficiency of perovskite solar cells (PSCs), the issues of toxicity and device instability have hampered the commercialization of this renewable energy technology. Lead (Pb) being the main culprit creates major environmental risks and therefore must be replaced with a nontoxic material such as tin (Sn), germanium (Ge), etc. Moreover, replacing organic cations in the perovskite's ABX3 structure with inorganic ones like cesium (Cs) helps aid the stability issues. This study uses six different kesterite-based hole transport layers (HTLs) and three different metal oxide-based electron transport layers (ETLs) to numerically simulate and optimize all-inorganic CsSnGeI3 PSCs. Metal oxide ETLs are used in this study due to their large band gap, while kesterite HTLs are used due to their excellent conductive properties. All of the simulations are performed under standard testing conditions. A total of 18 novel planar (n-i-p) PSCs are modeled by the combination of various charge transport layers (CTLs), and the device optimization was done to enhance the power conversion efficiencies (PCEs) of the PSCs. Furthermore, the effect of CTLs on the energy band alignment, electric field, quantum efficiency, light absorption, and recombination rate is analyzed. Additionally, a detailed analysis of the impact of defect density (Nt), interface defects (ETL/Perv, Perv/HTL), temperature, and work function on the functionality of 18 different CsSnGeI3-based PSCs is conducted. The simulation findings demonstrate that SnO2/CsSnGeI3/CNTS is the most efficient optimized PSC among all of the simulated structures, with a PCE of 27.33%, Jsc of 28.04 mA/cm2, FF of 85%, and Voc of 1.14 V.

Urtica pilulifera leaves extract mitigates cadmium induced hepatotoxicity via modulation of antioxidants, inflammatory markers and Nrf-2 signaling in mice.

Introduction: Cadmium (Cd) is a harmful heavy metal that results in many toxic issues. Urtica pilulifera showed potential pharmaceutical applications. This study investigated the possible ameliorative mechanism of Urtica pilulifera leaves extract (UPLE) against hepatotoxicity induced by cadmium chloride (CdCl2) in mice. Methods: In vitro phytochemical screening and the metal-chelating activity of UPLE were ascertained. Four groups of forty male mice were used (n = 10) as follows; Group 1 (G1) was a negative control. G2 was injected i.p., with UPLE (100mg/kg b. wt) daily. G3 was injected i.p., with Cd (5mg/kg b. wt) daily. G4 was injected with Cd as in G3 and with UPLE as in G2. On day 11, the body weight changes were evaluated, blood, and serum samples were collected for hematological and biochemical assessments. Liver tissues were used for biochemical, molecular, and histopathological investigations. Results: The results showed that UPLE contains promising secondary metabolites that considerably lessen the negative effects of Cd on liver. Furthermore, UPLE inhibited oxidative stress and inflammation; restored antioxidant molecules; and promoted nuclear-related factor-2 (Nrf-2) expression. Also, UPLE improved the histopathological alterations induced by Cd. Discussion: This study explored the beneficial role of UPLE treatment in Cd-induced liver injury through enhancing Nrf-2 signaling and antioxidant enzyme gene expression in the liver of mice. Therefore, UPLE could have valuable implications against hepatotoxicity induced by environmental cadmium exposure. Which can be used as a chelating agent against Cd.